Company / Working Capital
STAAR Surgical Company Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$243.0M
FY2025
5-year range
$222.6M / $300.2M
FY2021-FY2025
Trend
-18.3%
vs FY2024
Sector context
#101 of 160
Health Care
What the data says
At $243M, STAAR Surgical Company's working capital ranks #101 of 160 in the Health Care sector. Declined from $300M to $243M over the past 2 years.
Based on SEC 10-K filings.
$243M in FY2025 with a 5-year CAGR of +6.8%.
Declined from $300M to $243M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -2.2%
- 5-Year CAGR
- +6.8%
- 10-Year CAGR
- -
Sector benchmark
#101 of 160 in Health CareTop 63% of 160This company $243.0M Sector average $757.1M
▼
-67.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.8%, indicating consistent growth.
- In FY2025, working capital decreased 18.3% year-over-year.
- Ranks #101 out of 160 companies in the Health Care sector.
- Peak working capital was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $243.0M | -18.3% |
| FY2024 | $297.6M | -0.9% |
| FY2023 | $300.2M | +15.5% |
| FY2022 | $260.0M | +16.8% |
| FY2021 | $222.6M | +27.1% |
| FY2020 | $175.2M | +25.0% |
| FY2019 | $140.2M | +13.2% |
| FY2018 | $123.8M | +255.9% |
| FY2017 | $34.8M | +22.3% |
| FY2016 | $28.4M | -8.8% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026